Job Recruitment Website - Immigration policy - Li Xiting is the richest man in Forbes 2022 Singapore Rich List. How to evaluate his achievements in business?
Li Xiting is the richest man in Forbes 2022 Singapore Rich List. How to evaluate his achievements in business?
Mindray Medical founded by Li Xiting is also known as? Huawei in the medical field? The most famous private medical device company in China, with a market value of over 560 billion RMB at its peak, is firmly in the leading position of domestic medical devices. Li Xiting, who has just turned 70, staged a business legend from an Anhui farmer to the richest man in Singapore. 195 1 year, Li Xiting was born in an ordinary peasant family in Litun Village, Dangshan County, Anhui Province. He loved reading since he was a child, and his grades were excellent. It is appropriate to continue to enter a key university, but unfortunately, he caught up with the Cultural Revolution and the university closed. /kloc-Li Xiting, 0/8 years old, can only be enlisted in the army and worked as an engineer in the mountains and forests for 4 years. 1973, Li Xiting, who has been studying hard, was admitted to the Low Temperature Physics Group of Physics Department of China University of Science and Technology with excellent results, and was assigned to work in the Institute of Physics of Wuhan Chinese Academy of Sciences after graduation. Reading really changed his life.
1985, Li Xiting who came back from studying abroad was arranged to go to Shenzhen? Anke? The company is the director of the office. This? Anke? Is the earliest medical device company in China. After overseas companies sold medical equipment at high prices and domestic hospitals were unable to compete, Li Xiting decided to go into business. Li Xiting, who found a huge gap in domestic medical devices, founded Mindray Medical with six other colleagues in 199 1 and started to work alone, catching up with the dividend of reform and opening up. The company soon developed the first one in China? Multi-parameter oxygen saturation monitor I got the first investment from Wall Street. Monitor is the most mature product in Mindray Medical's three product lines. After continuous technical improvement, it has achieved a leap from low-end to high-end models, and its market share ranks first in China.
The substantial improvement of independent research and development capabilities has made Mindray Medical famous. When the COVID-19 epidemic is prevalent all over the world and there is a strong demand for ventilators, monitors and other equipment, Mindray Medical can? Take a deep breath And ushered in its own outbreak. The output of foreign medical device manufacturers can't keep up, and they all gradually agree to cooperate, which has become the biggest key to asset growth. At its peak, its company's market value rose by more than 800 million per day on average. Although Li Xiting has long been a Singaporean citizen, his career has been in China, and Mindray is also a purely private enterprise in China. Mindray is the first China medical device company listed in the United States. Listing in the United States is the fastest and most effective way to build trust with international customers. After privatization, Mindray decisively withdrew from the United States and then returned to A shares.
- Related articles
- Jinhua traffic police motor vehicle violation
- What's the best place to go to Canada?
- As an electrician in New Zealand, is your income guaranteed?
- What are the top ten classic bbc documentaries?
- Who are the authors of Tumen and Qinqiang Opera?
- Blessed or unlucky? Experts say that Britain's withdrawal from the EU will widen the gap between the top six teams in the Premier League and the teams in the middle and lower reaches.
- Analysis of favorable areas for mineralization
- Immigrants who perished in the Southern Song Dynasty
- 2012 Postgraduate Entrance Examination English Answers: Analysis of the Answers to the Postgraduate Examination English II Questions
- What do you think of Ekin Cheng and Yoyo Mung emigrating to Japan?